| Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity NS Azad, EM Posadas, VE Kwitkowski, SM Steinberg, L Jain, ... Journal of clinical oncology: official journal of the American Society of …, 2008 | 380 | 2008 |
| Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma T Vagner, C Spinelli, VR Minciacchi, L Balaj, M Zandian, A Conley, ... Journal of extracellular vesicles 7 (1), 1505403, 2018 | 327 | 2018 |
| Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy SG Zhao, SL Chang, N Erho, M Yu, J Lehrer, M Alshalalfa, C Speers, ... JAMA oncology 3 (12), 1663-1672, 2017 | 264 | 2017 |
| Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma JC Ahn, PC Teng, PJ Chen, E Posadas, HR Tseng, SC Lu, JD Yang Hepatology 73 (1), 422-436, 2021 | 245 | 2021 |
| Phase II study of dasatinib in patients with metastatic castration-resistant prostate cancer EY Yu, G Wilding, E Posadas, M Gross, S Culine, C Massard, MJ Morris, ... Clinical Cancer Research 15 (23), 7421-7428, 2009 | 244 | 2009 |
| Large oncosomes mediate intercellular transfer of functional microRNA M Morello, V Minciacchi, P de Candia, J Yang, E Posadas, H Kim, ... Cell cycle 12 (22), 3526-3536, 2013 | 242 | 2013 |
| Targeted therapies for renal cell carcinoma EM Posadas, S Limvorasak, RA Figlin Nature Reviews Nephrology 13 (8), 496-511, 2017 | 232 | 2017 |
| Fyn: a novel molecular target in cancer YD Saito, AR Jensen, R Salgia, EM Posadas Cancer: Interdisciplinary International Journal of the American Cancer …, 2010 | 228 | 2010 |
| Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis S Josson, M Gururajan, SY Sung, P Hu, C Shao, HE Zhau, C Liu, ... Oncogene 34 (21), 2690-2699, 2015 | 214 | 2015 |
| A phase II clinical trial of sorafenib in androgen-independent prostate cancer WL Dahut, C Scripture, E Posadas, L Jain, JL Gulley, PM Arlen, JJ Wright, ... Clinical cancer research 14 (1), 209-214, 2008 | 208 | 2008 |
| Safety and efficacy of BIND-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer: a … KA Autio, R Dreicer, J Anderson, JA Garcia, A Alva, LL Hart, MI Milowsky, ... JAMA oncology 4 (10), 1344-1351, 2018 | 198 | 2018 |
| A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer EM Posadas, MS Liel, V Kwitkowski, L Minasian, AK Godwin, MM Hussain, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 176 | 2007 |
| High‐purity prostate circulating tumor cell isolation by a polymer nanofiber‐embedded microchip for whole exome sequencing L Zhao, YT Lu, F Li, K Wu, S Hou, J Yu, Q Shen, D Wu, M Song, ... Advanced materials 25 (21), 2897-2902, 2013 | 175 | 2013 |
| Dasatinib combined with docetaxel for castration‐resistant prostate cancer: results from a phase 1‐2 study JC Araujo, P Mathew, AJ Armstrong, EL Braud, E Posadas, M Lonberg, ... Cancer 118 (1), 63-71, 2012 | 167 | 2012 |
| Proteomic analysis for the early detection and rational treatment of cancer—realistic hope? EM Posadas, F Simpkins, LA Liotta, C MacDonald, EC Kohn Annals of oncology 16 (1), 16-22, 2005 | 163 | 2005 |
| NanoVelcro Chip for CTC enumeration in prostate cancer patients YT Lu, L Zhao, Q Shen, MA Garcia, D Wu, S Hou, M Song, X Xu, ... Methods 64 (2), 144-152, 2013 | 157 | 2013 |
| Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring N Sun, YT Lee, RY Zhang, R Kao, PC Teng, Y Yang, P Yang, JJ Wang, ... Nature communications 11 (1), 4489, 2020 | 153 | 2020 |
| miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer S Josson, M Gururajan, P Hu, C Shao, GCY Chu, HE Zhau, C Liu, K Lao, ... Clinical cancer research 20 (17), 4636-4646, 2014 | 147 | 2014 |
| MYC mediates large oncosome-induced fibroblast reprogramming in prostate cancer VR Minciacchi, C Spinelli, M Reis-Sobreiro, L Cavallini, S You, M Zandian, ... Cancer research 77 (9), 2306-2317, 2017 | 140 | 2017 |
| Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review G Leonard, E Posadas, P Herrmann, V Anderson, E Jaffe, S Holland, ... Leukemia & lymphoma 45 (12), 2521-2525, 2004 | 129 | 2004 |
Hsian-Rong Tseng (曾憲榮)Professor, Department of Molecular and Medical Pharmacology, UCLA在 mednet.ucla.edu 的電子郵件地址已通過驗證
